242543
プロピルアミン 塩酸塩
≥99%
別名:
1-アミノプロパン 塩酸塩
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
化学式:
CH3CH2CH2NH2·HCl
CAS番号:
分子量:
95.57
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
209-129-9
MDL number:
Assay:
≥99%
Form:
solid
Quality Segment
assay
≥99%
form
solid
mp
160-162 °C (lit.)
solubility
water: soluble 100 mg/mL, clear, colorless
functional group
amine
SMILES string
Cl[H].CCCN
InChI
1S/C3H9N.ClH/c1-2-3-4;/h2-4H2,1H3;1H
InChI key
PYNUOAIJIQGACY-UHFFFAOYSA-N
Application
Propylamine hydrochloride was used to study the liquid chromatographic behavior of potassium-sparing and loop diuretics.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
F De Croo et al.
Journal of chromatography, 325(2), 395-411 (1985-06-07)
This paper deals with the specific identification of several thiazide, potassium-sparing and loop diuretics. The liquid chromatographic behaviour of these compounds is studied. Different organic modifiers (methanol, acetonitrile and tetrahydrofuran) are compared in terms of selectivity for the thiazide diuretics.
Rui Tao et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 39(8), 1996-2007 (2014-03-01)
Drug interaction between inhibitors of monoamine oxidase (MAOIs) and selective serotonin (5-hydroxytryptamine, 5-HT) reuptake (SSRIs) induces serotonin syndrome, which is usually mild but occasionally severe in intensity. However, little is known about neural mechanisms responsible for the syndrome induction and
Sarah W Black et al.
Biological psychiatry, 82(9), 623-633 (2016-12-07)
Narcolepsy, a disorder of rapid eye movement (REM) sleep, is characterized by excessive daytime sleepiness and cataplexy, a loss of muscle tone triggered by emotional stimulation. Current narcolepsy pharmacotherapeutics include controlled substances with abuse potential or drugs with undesirable side